CUSIP: 30233M107
Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
626,176
-
Share change
-
+97,240
-
Total reported value
-
$1,038,000
-
Price per share
-
$1.74
-
Number of holders
-
9
-
Value change
-
+$106,118
-
Number of buys
-
4
-
Number of sells
-
5
Quarterly Holders Quick Answers
What is CUSIP 30233M107?
CUSIP 30233M107 identifies EYEG - EYEGATE PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2016
-
Previous quarter:
Q2 2016
Recent filing periods for CUSIP 30233M107:
Institutional Holders of EYEGATE PHARMACEUTICALS INC - COM (EYEG) as of Q3 2016
As of 30 Sep 2016,
EYEGATE PHARMACEUTICALS INC - COM (EYEG) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
626,176 shares.
The largest 9 holders included
SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, IFP Advisors, Inc, BlackRock Fund Advisors, SUMMIT SECURITIES GROUP, LLC, Vantage Investment Advisors, LLC, Tower Research Capital LLC (TRC), BlackRock Investment Management, LLC, and BANK OF AMERICA CORP /DE/.
This page lists
9
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.